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Sir, 
We have read with great interest the recently published paper “Management 
of radiotherapy-induced salivary hypofunction and consequent xerostomia in patients 
with oral or head and neck cancer: meta-analysis and literature review” by Lovelace 
et al (1). We certainly agree with the authors that there is little evidence-based 
guidance for clinicians as regards the efficacy of available treatments for 
hyposalivation and xerostomia associated with head and neck radiotherapy. We also 
share their concerns regarding the limited number of available randomized controlled 
trials and the great variability in the definition and measurements of hyposalivation 
and xerostomia, as well as the lack of quality of life data. This can affect robustness 
of available evidence and hinder comparison and pooling of data from different 
studies. Therefore we applaud their attempt to perform a much needed systematic 
review and meta-analysis on the topic.  
However, systematic review and meta-analyses require rigorous research methods 
in order to limit bias and provide a more reliable and enhanced precision of effect 
estimate than those achieved in individual studies. Strict rules apply so to synthesize 
the results of multiple primary investigations and generate the necessary, validated 
high levels of evidence that can guide clinical decision making and support practice 
guidelines (2, 3). When methodological rigor is not diligently applied, systematic 
review and meta-analyses can be subject to bias and can be flawed (3), with several 
examples being reported where serious errors have been identified (4, 5). Systematic 
reviews of questionable validity can be misleading and have the potential for an 
adverse impact on clinical practice. 
We have identified a number of methodological issues in the work of Lovelace et al 
that carry a significant risk of affecting validity of their results.  
1. Authors searched only one electronic database (Pubmed/MEDLINE) for studies 
reporting on treatment options for radiation-induced xerostomia in patients with 
head and neck cancer. Most systematic reviews search multiple databases 
(MEDLINE, EMBASE, CENTRAL) in order to increase coverage and maximize 
the number of studies to be considered (6, 7). Cochrane’s and other guidelines 
clearly point out that a search of MEDLINE database alone is not adequate (8). 
Indeed it has been reported that the average sensitivity of Medline searching can 
be as low as 51% when all known trials are considered as gold standard, and 
not higher than 77% even when only trials published in journals available in 
Medline are used as gold standard (9). 
2. Restricting the search to electronic databases carries a significant risk of 
excluding relevant studies (8, 10) and having an incorrect effect estimate 
because of exclusion of grey literature (11). Current guidelines recommend the 
use of supplementary approaches to maximize the chances of identifying all 
relevant studies (8, 10, 12).  Lovelace et al did search references from identified 
studies; however they do not seem to have performed any of the other 
recommended supplementary search methods including hand searching of key 
journals, conference proceedings, as well as search of trials registries or 
regulatory agency websites.  
3. Current guidelines on performing and reporting systematic reviews (Cochrane 
Handbook and PRISMA statement) (8, 12), clearly state that authors should 
report the start and end dates for the search of each database, so to allow 
readers to assess the recency of the review. Considerable delays between 
search and publication are not uncommon, with a relatively recent analysis of 
100 systematic reviews suggesting that 7% of them were already out of date on 
the day of publication (13). 
4. Publication language was limited to English, although it is well reported that 
reviews exclusively based upon English-language reports are at higher risk of 
bias (14, 15). We wonder why authors did not mention the potential importance 
of language bias among the limitations of their meta-analysis. 
5. The authors included a prospective controlled study (16), which however is a 
review of two randomized, placebo-controlled, multicenter trials previously 
published and already included in the systematic review (17, 18). The inclusion 
of duplicated data is a well recognised cause of bias and may lead to 
overestimate intervention effects (19). 
6. The authors selected and included a prospective controlled study that addressed 
treatment of hyposalivation/xerostomia with hyperbaric oxygen therapy (20). In 
this paper Teguh et al recruited patients who were due to have radiotherapy, 
which is in clear contrast with inclusion criteria stated by Lovelace et al “agent or 
procedure initiated after radiation therapy”. These individuals were not 
complaining of xerostomia and did not present with hyposalivation at the time of 
recruitment and randomization. Also, this trial was stopped prematurely, with 
only 19 patients having been recruited out of 132 needed as per protocol and 
sample size calculation (20). We wonder whether inclusion of this paper is 
appropriate. 
7. The authors also included a placebo-controlled randomized trial of topical 
pilocarpine dose escalation by Hamlar et al (21). However this study presents a 
number of serious methodological issues, including unclear study design and 
lack of randomization in allocating participants to dose escalation, and we 
suggest that should have not been included into a systematic review. Indeed this 
very same paper was excluded from a previous systematic review on the 
management of dry mouth with topical therapies (22). 
8. The authors assessed the risk of bias in the selected studies using the Jadad 5-
point questionnaire but reported only summary data (‘‘eleven of the fourteen 
studies included in the review received a score of 4 or 5”), therefore failing to 
inform readers about the actual studies that had a particular methodological 
shortcoming. A more informative approach is recommended in order to report 
explicitly the methodological features evaluated for each study. It is often 
advised to provide these data in a tabular format or graphs (8, 12). 
9. PRISMA guidelines clearly recommend that authors identify their work as a 
systematic review in the title (12). The terms ‘‘literature review’’ do not describe 
whether the review was systematic or narrative, which would confuse readers 
and potentially affect indexing and identification.  
We feel that the above points raise significant doubts about the accuracy and the 
validity of the meta-analysis. 
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